Deutsche Bank’s Insmed INSM Stock Holding History

Deutsche Bank’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-773	Closed	-$1K	–	5538
2013 Q3	$1K	Buy	+773	New	+$9.82K	﹤0.01%	5411

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank's INSM Position: Q1 2026 in Review

Deutsche Bank reduced its Insmed (INSM) stake by 4.7% in Q1 2026, selling an estimated $4.24M and leaving 562,474 shares worth $92M. The position accounts for 0.03% of the portfolio, ranked #498.

Deutsche Bank first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Deutsche Bank held 562,474 shares of Insmed worth $92M as of Q1 2026.
Deutsche Bank sold 27,556 Insmed shares in Q1 2026, an estimated $4.24M.
Insmed made up 0.03% of Deutsche Bank's portfolio in Q1 2026, its #498 holding.
Deutsche Bank first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Insmed position peaked at $103M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.